Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Pre-Clinical Activity of Combined LSD1 and mTORC1 Inhibition in MLL-translocated Acute Myeloid Leukaemia

Leukemia

English

A Regimen Combining the Wee1 Inhibitor AZD1775 With HDAC Inhibitors Targets Human Acute Myeloid Leukemia Cells Harboring Various Genetic Mutations

English

Neutralization of (NK-cell-derived) B-Cell Activating Factor by Belimumab Restores Sensitivity of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

English

Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

English

Phase I Trial and Pharmacokinetic Study of High-Dose Clofarabine and Busulfan and Allogeneic Stem Cell Transplantation in Adults With High-Risk and Refractory Acute Leukemia

English

WTAP Is a Novel Oncogenic Protein in Acute Myeloid Leukemia

English

Proteasome Inhibitor-Adapted Myeloma Cells Are Largely Independent From Proteasome Activity and Show Complex Proteomic Changes, in Particular in Redox and Energy Metabolism

English

Hematopoietic Stem Cell Transplantation in T-Prolymphocytic Leukemia: A Retrospective Study From the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium

English

Baseline Differential Blood Count and Prognosis in CD20-positive Post-Transplant Lymphoproliferative Disorder in the Prospective PTLD-1 Trial

English

European LeukemiaNet Recommendations for the Management and Avoidance of Adverse Events of Treatment in Chronic Myeloid Leukaemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Pre-Clinical Activity of Combined LSD1 and mTORC1 Inhibition in MLL-translocated Acute Myeloid Leukaemia

A Regimen Combining the Wee1 Inhibitor AZD1775 With HDAC Inhibitors Targets Human Acute Myeloid Leukemia Cells Harboring Various Genetic Mutations

Neutralization of (NK-cell-derived) B-Cell Activating Factor by Belimumab Restores Sensitivity of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

Phase I Trial and Pharmacokinetic Study of High-Dose Clofarabine and Busulfan and Allogeneic Stem Cell Transplantation in Adults With High-Risk and Refractory Acute Leukemia

WTAP Is a Novel Oncogenic Protein in Acute Myeloid Leukemia

Proteasome Inhibitor-Adapted Myeloma Cells Are Largely Independent From Proteasome Activity and Show Complex Proteomic Changes, in Particular in Redox and Energy Metabolism

Hematopoietic Stem Cell Transplantation in T-Prolymphocytic Leukemia: A Retrospective Study From the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium

Baseline Differential Blood Count and Prognosis in CD20-positive Post-Transplant Lymphoproliferative Disorder in the Prospective PTLD-1 Trial

European LeukemiaNet Recommendations for the Management and Avoidance of Adverse Events of Treatment in Chronic Myeloid Leukaemia